205 related articles for article (PubMed ID: 23151972)
1. Mental health disorders influence admission rates for pain in children with sickle cell disease.
Myrvik MP; Burks LM; Hoffman RG; Dasgupta M; Panepinto JA
Pediatr Blood Cancer; 2013 Jul; 60(7):1211-4. PubMed ID: 23151972
[TBL] [Abstract][Full Text] [Related]
2. Impact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia.
Myrvik MP; Campbell AD; Davis MM; Butcher JL
Pediatr Blood Cancer; 2012 Feb; 58(2):239-43. PubMed ID: 21425450
[TBL] [Abstract][Full Text] [Related]
3. Admission and length of stay due to painful vasoocclusive crisis in children.
Rogovik AL; Li Y; Kirby MA; Friedman JN; Goldman RD
Am J Emerg Med; 2009 Sep; 27(7):797-801. PubMed ID: 19683107
[TBL] [Abstract][Full Text] [Related]
4. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
[TBL] [Abstract][Full Text] [Related]
5. Hospitalisations for sickle-cell disease in an Australian paediatric population.
Teoh Y; Greenway A; Savoia H; Monagle P; Roy J; Barnes C
J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
[TBL] [Abstract][Full Text] [Related]
6. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
7. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
Akar NA; Adekile A
Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
[TBL] [Abstract][Full Text] [Related]
8. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
Allen Liles E; Kirsch J; Gilchrist M; Adem M
Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease.
Zempsky WT; Loiselle KA; McKay K; Blake GL; Hagstrom JN; Schechter NL; Kain ZN
Pediatr Blood Cancer; 2008 Aug; 51(2):265-8. PubMed ID: 18386784
[TBL] [Abstract][Full Text] [Related]
10. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
Panepinto JA; Brousseau DC; Hillery CA; Scott JP
Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
[TBL] [Abstract][Full Text] [Related]
11. Shorter hospitalization trends among children with sickle cell disease.
Raphael JL; Mueller BU; Kowalkowski MA; Oyeku SO
Pediatr Blood Cancer; 2012 Oct; 59(4):679-84. PubMed ID: 22223395
[TBL] [Abstract][Full Text] [Related]
12. Depression and anxiety in adults with sickle cell disease: the PiSCES project.
Levenson JL; McClish DK; Dahman BA; Bovbjerg VE; de A Citero V; Penberthy LT; Aisiku IP; Roberts JD; Roseff SD; Smith WR
Psychosom Med; 2008 Feb; 70(2):192-6. PubMed ID: 18158366
[TBL] [Abstract][Full Text] [Related]
13. Impact of individualized pain plan on the emergency management of children with sickle cell disease.
Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R
Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217
[TBL] [Abstract][Full Text] [Related]
14. Impact of environmental tobacco smoke on children with sickle cell disease.
West DC; Romano PS; Azari R; Rudominer A; Holman M; Sandhu S
Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1197-201. PubMed ID: 14662575
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
Stallworth JR; Jerrell JM; Tripathi A
Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Geographic Characterization of 30-Day Readmissions in Pediatric Sickle Cell Crisis Patients.
McMillan JE; Meier ER; Winer JC; Coco M; Daymont M; Long S; Jacobs BR
Hosp Pediatr; 2015 Aug; 5(8):423-31. PubMed ID: 26231632
[TBL] [Abstract][Full Text] [Related]
17. Safety of deep sedation in young children with sickle cell disease: a retrospective cohort study.
Belmont AP; Nossair F; Brambilla D; Friedman M; Boswinkel J; Bradford AB; Kwiatkowski JL
J Pediatr; 2015 May; 166(5):1226-32. PubMed ID: 25919732
[TBL] [Abstract][Full Text] [Related]
18. Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10.
Aljuburi G; Laverty AA; Green SA; Phekoo KJ; Banarsee R; Okoye NV; Bell D; Majeed A
J Public Health (Oxf); 2012 Dec; 34(4):570-6. PubMed ID: 22653886
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
[TBL] [Abstract][Full Text] [Related]
20. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
